Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The synthetic triterpenoid, CDDO-Imidazolide, activates heme oxygenase-1 and other Nrf2-responsive genes in human leukemia cells

The synthetic triterpenoid, CDDO-Imidazolide, activates heme oxygenase-1 and other Nrf2-responsive genes in human leukemia cells . Proceedings of the 95th Annual Meeting of the American Association for Cancer Research. 2004; 318.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.